Centogene
Michael Rothhaar has extensive experience in quality assurance and regulatory affairs. Michael'smost recent role was as the Vice President of Quality & Regulatory Affairs at CENTOGENE. Prior to that, they served as the Head of Quality Assurance & Control ST (Global Director Pos.) & PRRC at Sartorius Stedim Biotech. Michael also held positions as the Director of Global Quality Supply Chain at HOYA Surgical Optics, the Head of Quality Assurance at Roche, and the Quality Representative / Head of QA Supply Chain Capital Equipment at Getinge. Michael has also worked at Vitaphone GmbH as the Director of Corporate Quality / Regulatory Affairs and at ASS Elektronik GmbH as the Prokurist and Quality Manager / Regulatory Affairs. Michael began their career at TRW A E & C GmbH & Co. KG as an IT Project Support.
From 2001 to 2005, Michael Rothhaar attended Wirtschaftsfachschule Kaiserslautern where they obtained a degree in Betriebswirtschaft Fachrichtung Informationsverarbeitung, earning the title of Staatl. gepr. Betriebswirt.
This person is not in the org chart
Centogene
2 followers
Centogene BV is a Germany-based company engaged in the rare disease market. It focuses on transforming clinical, genetic and biochemical data into medical solutions for patients, physicians and pharmaceutical companies. The Company provides the full spectrum of methods and technology for human genetics analysis. It develops a rare disease platform based on its real-world data repository with over 2.0 billion weighted data points from over 450, 000 patients representing around 115 different, which includes epidemiologic, phenotypic and genetic data that reflects a global population, as well as a biobank of patients' blood samples. In addition, it is active in the research and development products for human genetics. The Company operates in Germany and the United States.